The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aldactone 25mg Film-coated Tablets

25 milligram(s) Film-coated tablet

LTT Pharma LimitedPPA1562/133/001

Main Information

Trade NameAldactone 25mg Film-coated Tablets
Active SubstancesSpironolactone
Strength25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/133/001

Group Information

ATC CodeC03DA Aldosterone antagonists
C03DA01 spironolactone

Status

Authorised/WithdrawnAuthorised
Licence Issued24/10/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0822/110/001.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back